133 related articles for article (PubMed ID: 15905588)
1. Flt3 ligand treatment reverses endotoxin tolerance-related immunoparalysis.
Wysocka M; Montaner LJ; Karp CL
J Immunol; 2005 Jun; 174(11):7398-402. PubMed ID: 15905588
[TBL] [Abstract][Full Text] [Related]
2. IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness.
Wysocka M; Robertson S; Riemann H; Caamano J; Hunter C; Mackiewicz A; Montaner LJ; Trinchieri G; Karp CL
J Immunol; 2001 Jun; 166(12):7504-13. PubMed ID: 11390504
[TBL] [Abstract][Full Text] [Related]
3. Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties.
Miller G; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP
J Immunol; 2003 Apr; 170(7):3554-64. PubMed ID: 12646617
[TBL] [Abstract][Full Text] [Related]
4. LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism.
Fallarino F; Pallotta MT; Matino D; Gargaro M; Orabona C; Vacca C; Mondanelli G; Allegrucci M; Boon L; Romani R; Talesa VN; Puccetti P; Grohmann U
Immunobiology; 2015 Feb; 220(2):315-21. PubMed ID: 25278421
[TBL] [Abstract][Full Text] [Related]
5. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
[TBL] [Abstract][Full Text] [Related]
6. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy.
Shaw SG; Maung AA; Steptoe RJ; Thomson AW; Vujanovic NL
J Immunol; 1998 Sep; 161(6):2817-24. PubMed ID: 9743341
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Dendritic Cell-Derived IL-12 by Endogenous Glucocorticoids Is Protective in LPS-Induced Sepsis.
Li CC; Munitic I; Mittelstadt PR; Castro E; Ashwell JD
PLoS Biol; 2015 Oct; 13(10):e1002269. PubMed ID: 26440998
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic treatment with fms-like tyrosine kinase-3 ligand after burn injury enhances global immune responses to infection.
Bohannon J; Cui W; Cox R; Przkora R; Sherwood E; Toliver-Kinsky T
J Immunol; 2008 Mar; 180(5):3038-48. PubMed ID: 18292526
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic Profiles in Children With Septic Shock With or Without Immunoparalysis.
Snyder A; Jedreski K; Fitch J; Wijeratne S; Wetzel A; Hensley J; Flowers M; Bline K; Hall MW; Muszynski JA
Front Immunol; 2021; 12():733834. PubMed ID: 34659221
[TBL] [Abstract][Full Text] [Related]
10. The immune response modifier and Toll-like receptor 7 agonist S-27609 selectively induces IL-12 and TNF-alpha production in CD11c+CD11b+CD8- dendritic cells.
Doxsee CL; Riter TR; Reiter MJ; Gibson SJ; Vasilakos JP; Kedl RM
J Immunol; 2003 Aug; 171(3):1156-63. PubMed ID: 12874201
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin-induced maturation of MyD88-deficient dendritic cells.
Kaisho T; Takeuchi O; Kawai T; Hoshino K; Akira S
J Immunol; 2001 May; 166(9):5688-94. PubMed ID: 11313410
[TBL] [Abstract][Full Text] [Related]
12. Processing Body Formation Limits Proinflammatory Cytokine Synthesis in Endotoxin-Tolerant Monocytes and Murine Septic Macrophages.
McClure C; Brudecki L; Yao ZQ; McCall CE; El Gazzar M
J Innate Immun; 2015; 7(6):572-83. PubMed ID: 25998849
[TBL] [Abstract][Full Text] [Related]
13. Nasal Flt3 ligand cDNA elicits CD11c+CD8+ dendritic cells for enhanced mucosal immunity.
Kataoka K; McGhee JR; Kobayashi R; Fujihashi K; Shizukuishi S; Fujihashi K
J Immunol; 2004 Mar; 172(6):3612-9. PubMed ID: 15004163
[TBL] [Abstract][Full Text] [Related]
14. FLT3-ligand administration inhibits liver metastases: role of NK cells.
Péron JM; Esche C; Subbotin VM; Maliszewski C; Lotze MT; Shurin MR
J Immunol; 1998 Dec; 161(11):6164-70. PubMed ID: 9834102
[TBL] [Abstract][Full Text] [Related]
15. Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance.
Karp CL; Wysocka M; Ma X; Marovich M; Factor RE; Nutman T; Armant M; Wahl L; Cuomo P; Trinchieri G
Eur J Immunol; 1998 Oct; 28(10):3128-36. PubMed ID: 9808181
[TBL] [Abstract][Full Text] [Related]
16. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo.
Borges L; Miller RE; Jones J; Ariail K; Whitmore J; Fanslow W; Lynch DH
J Immunol; 1999 Aug; 163(3):1289-97. PubMed ID: 10415026
[TBL] [Abstract][Full Text] [Related]
17. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo.
Pulendran B; Banchereau J; Burkeholder S; Kraus E; Guinet E; Chalouni C; Caron D; Maliszewski C; Davoust J; Fay J; Palucka K
J Immunol; 2000 Jul; 165(1):566-72. PubMed ID: 10861097
[TBL] [Abstract][Full Text] [Related]
18. Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant.
Pulendran B; Smith JL; Jenkins M; Schoenborn M; Maraskovsky E; Maliszewski CR
J Exp Med; 1998 Dec; 188(11):2075-82. PubMed ID: 9841921
[TBL] [Abstract][Full Text] [Related]
19. Flt3 ligand preferentially increases the number of functionally active myeloid dendritic cells in the lungs of mice.
Masten BJ; Olson GK; Kusewitt DF; Lipscomb MF
J Immunol; 2004 Apr; 172(7):4077-83. PubMed ID: 15034019
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells from malaria-infected mice are fully functional APC.
Perry JA; Rush A; Wilson RJ; Olver CS; Avery AC
J Immunol; 2004 Jan; 172(1):475-82. PubMed ID: 14688357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
